Kreatech Diagnostics develops and markets molecular diagnostics worldwide allowing health care providers to make informed decisions about the treatment of patients. Kreatech offers the broadest commercial portfolio available of Fluorescent in Situ Hybridization probes for both diagnostic and research use.
Kreatech's proprietary labeling technology, the Universal Linkage System (ULS™), allows accurate (non-enzymatic) and fast labeling of DNA, RNA and proteins; one universal system compatible with all biological samples.

Web: www.kreatech.com